Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cellular and molecular neurobiology

• Publication date

  2019-09-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10571-019-00731-2PMID 31482432PMCID PMC11448812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression Profile of Long Non-Coding RNAs during Early Postnatal Development of Mouse Spinal Cord

  2020cited by this paper
• Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients

  2019cited by this paper
• The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.

  2019cited by this paper
• Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients.

  2018cited by this paper
• Down-regulation of RORA gene expression in the blood of multiple sclerosis patients

  2018cited by this paper
• IFNAR1 expression level in Iranian multiple sclerosis patients treated with IFN-B

  2018cited by this paper
• Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis

  2018cited by this paper
• Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course

  2018cited by this paper
• HLA class II polymorphism in Saudi patients with multiple sclerosis

  2018cited by this paper
• Decreased serum levels of interleukin-35 among multiple sclerosis patients may be related to disease progression.

  2018cited by this paper
• Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a

  2018cited by this paper
• IL12B gene polymorphisms have sex-specific effects in relapsing–remitting multiple sclerosis

  2018cited by this paper
• The FOXP3 rs3761547 Gene Polymorphism in Multiple Sclerosis as a Male-Specific Risk Factor

  2018cited by this paper
• The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population

  2018cited by this paper
• Investigating the exon 6 sequence changes of interleukin 7 receptor A (IL7RA) gene in patients with relapsing-remitting multiple sclerosis

  2018cited by this paper
• HOTAIR but not ANRIL long non‐coding RNA contributes to the pathogenesis of multiple sclerosis

  2018cited by this paper
• Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.

  2018cited by this paper
• Vaccinia Related Kinase 2 (VRK2) expression in neurological disorders: schizophrenia, epilepsy and multiple sclerosis.

  2018cited by this paper
• Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients

  2017cited by this paper
• Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients.

  2017cited by this paper
• Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients

  2017cited by this paper
• Human glutathione s-transferase enzyme gene variations and risk of multiple sclerosis in Iranian population cohort.

  2017cited by this paper
• PER3 VNTR polymorphism in Multiple Sclerosis: A new insight to impact of sleep disturbances in MS.

  2017cited by this paper
• Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle

  2017cited by this paper
• Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls

  2017cited by this paper
• Novel functional polymorphism in IGF-1 gene associated with multiple sclerosis: A new insight to MS.

  2017cited by this paper
• Association of rs1738074 polymorphism of TAGAP gene with susceptibility to multiple sclerosis in the Iranian population.

  2017cited by this paper
• Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients.

  2017cited by this paper
• Correlation of Serum Levels of IL-33, IL-37, Soluble Form of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), and Circulatory Frequency of VEGFR2-expressing Cells with Multiple Sclerosis Severity.

  2017cited by this paper
• Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments.

  2017cited by this paper
• PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.

  2017cited by this paper
• Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients

  2017cited by this paper
• Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis.

  2017cited by this paper
• Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

  2017cited by this paper
• Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis

  2017cited by this paper
• SOCS gene family expression profile in the blood of multiple sclerosis patients.

  2017cited by this paper
• Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

  2017cited by this paper
• An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple sclerosis

  2017cited by this paper
• Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population

  2017cited by this paper
• The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population.

  2017cited by this paper
• Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.

  2017cited by this paper
• Assessment of plasma biomarkers for their association with Multiple Sclerosis progression.

  2017cited by this paper
• Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

  2017cited by this paper
• Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults.

  2017cited by this paper
• Association between interleukin-32 polymorphism and multiple sclerosis.

  2017cited by this paper
• The Role of Long Non Coding RNAs in the Repair of DNA Double Strand Breaks

  2017cited by this paper
• Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin.

  2017cited by this paper
• Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis

  2016cited by this paper
• RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis.

  2016cited by this paper
• Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2

  2016cited by this paper
• Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis

  2016cited by this paper
• Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis

  2016cited by this paper
• Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.

  2016cited by this paper
• Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis

  2016cited by this paper
• The Association between Vascular Endothelial Growth Factor-related Factors with Severity of Multiple Sclerosis.

  2016cited by this paper
• Long non-coding RNAs in innate and adaptive immunity.

  2016cited by this paper
• Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.

  2016cited by this paper
• An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibility.

  2016cited by this paper
• The link between TLR7 signaling and hepatitis B virus infection.

  2016cited by this paper
• Long Non-coding RNA, PANDA, Contributes to the Stabilization of p53 Tumor Suppressor Protein.

  2016cited by this paper
• ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks

  2016cited by this paper
• Neurotherapeutic Strategies for Multiple Sclerosis.

  2016cited by this paper
• Vascular endothelial growth factor-A mRNA gene expression in clinical phases of multiple sclerosis

  2016cited by this paper
• Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).

  2016cited by this paper
• Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.

  2016cited by this paper
• Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis

  2016cited by this paper
• VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls.

  2016cited by this paper
• Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis

  2016cited by this paper
• Up regulation of MMP9 gene expression in female patients with multiple sclerosis

  2016cited by this paper
• Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.

  2016cited by this paper
• Risk factors in multiple sclerosis: a population-based case–control study in Sicily. Background and methods

  2016cited by this paper
• Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis

  2016cited by this paper
• Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis

  2016cited by this paper
• Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis.

  2016cited by this paper
• Association of TIM‐1 5383‐5397ins/del and TIM‐3 ‐1541C>T polymorphisms with multiple sclerosis in Isfahan population

  2016cited by this paper
• Positive Association of Vitamin D Receptor Gene Variations with Multiple Sclerosis in South East Iranian Population

  2015cited by this paper
• Sleep Disorders in Patients with Multiple Sclerosis

  2015cited by this paper
• Association of interleukin-1 gene cluster polymorphisms and haplotypes with multiple sclerosis in an Iranian population.

  2015cited by this paper
• Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis.

  2015cited by this paper
• Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing-remitting multiple sclerosis.

  2015cited by this paper
• Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions

  2015cited by this paper
• Decreased SOCS1 mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus in a Chinese population

  2015cited by this paper
• Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.

  2015cited by this paper
• Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica

  2015cited by this paper
• The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour

  2015cited by this paper
• Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients

  2015cited by this paper
• S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal‐regulated kinase and nuclear factor‐κB pathways

  2015cited by this paper
• Cytokines gene expression in newly diagnosed multiple sclerosis patients.

  2015cited by this paper
• HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population

  2015cited by this paper
• miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis

  2015cited by this paper
• S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis

  2015cited by this paper
• Effects of VRK2 (rs2312147) on White Matter Connectivity in Patients with Schizophrenia

  2014cited by this paper
• miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.

  2014cited by this paper
• Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.

  2014influential reference
• A human sleep homeostasis phenotype in mice expressing a primate-specific PER3 variable-number tandem-repeat coding-region polymorphism

  2014cited by this paper
• Evolutionary History of the PER3 Variable Number of Tandem Repeats (VNTR): Idiosyncratic Aspect of Primate Molecular Circadian Clock

  2014cited by this paper
• Oxidative Stress Induced by Lipid Peroxidation Is Related with Inflammation of Demyelination and Neurodegeneration in Multiple Sclerosis

  2014cited by this paper
• Vitamin D and multiple sclerosis

  2014cited by this paper
• Potential Impact of Air Pollution on Multiple Sclerosis in Tehran, Iran

  2014cited by this paper
• P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression

  2014cited by this paper

• Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?

  2024cites this paper
• Genetics of multiple sclerosis: lessons from polygenicity.

  2022cites this paper
• Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview

  2021cites this paper
• Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS

  2021cites this paper